The peptide binds copper through the N-terminal amine, histidine imidazole, and Gly-His amide nitrogen in a square-planar geometry
Equivilant to IV Therapy absorbtion at 97% - 100% into the bloodstream, at a fraction of the cost
Common side effects Nausea Vomiting Diarrhea Constipation Fatigue Decreased appetite Gas/burping Abdominal cramping Less common but more serious side effects Gallbladder issues Pancreatitis Severe digestive discomfort Kidney concerns in dehydrated individuals Providers often start patients on low doses to improve tolerability
Currently in Phase 3 clinical trials, retatrutide demonstrated unprecedented weight loss of up to 24.2% at 48 weeks in the Phase 2 trial published in the New England Journal of Medicine
L-Carnitine is a key element in the fat-burning process
He Z, Liao W, Song Q, Li B, Liu J, Xiong Y, et al